USD/YER
246.48/98
04-March-25 10:38:01
realtime
Forex
-0.10
-0.04%
Today's range
246.48 - 246.94
ISIN
FXUSDYER
Source
FX
-
Barclays Issues Positive Forecast for Fomento Económico Mexicano (NYSE:FMX) Stock Price
04 Mar 2025 09:01:13 By Buzz FX
-
Microchip Technology (NASDAQ:MCHP) Price Target Raised to $60.00 at TD Cowen
04 Mar 2025 09:01:13 By Buzz FX
-
Gilead Sciences (NASDAQ:GILD) Given New $132.00 Price Target at Oppenheimer
04 Mar 2025 09:01:13 By Buzz FX
-
D. Boral Capital Initiates Coverage on Tevogen Bio (NASDAQ:TVGN)
04 Mar 2025 09:01:13 By Buzz FX
-
Target highlights slowdown in US consumer spending
04 Mar 2025 09:00:22 By Buzz FX
-
Trump trades are upended as Treasury returns beat U.S. stocks
04 Mar 2025 08:51:15 By Buzz FX
-
Aussie housing market heats up following interest rate cut
04 Mar 2025 08:49:23 By Buzz FX
-
Kosmos Energy (NYSE:KOS) Lowered to Hold Rating by Benchmark
04 Mar 2025 08:49:15 By Buzz FX
-
Frontier Group (NASDAQ:ULCC) Lowered to Hold Rating by Deutsche Bank Aktiengesellschaft
04 Mar 2025 08:49:15 By Buzz FX
-
Canaccord Genuity Group Reiterates Buy Rating for Hut 8 (NASDAQ:HUT)
04 Mar 2025 08:49:15 By Buzz FX
-
Chart Industries (NYSE:GTLS) Price Target Raised to $165.00
04 Mar 2025 08:49:15 By Buzz FX
-
Medtronic (NYSE:MDT) Rating Increased to Buy at Citigroup
04 Mar 2025 08:49:15 By Buzz FX
-
Scotts Miracle-Gro (NYSE:SMG) Upgraded by Stifel Nicolaus to Buy Rating
04 Mar 2025 08:49:15 By Buzz FX
-
Hawaiian Electric Industries (NYSE:HE) Stock Price Expected to Rise, Barclays Analyst Says
04 Mar 2025 08:49:15 By Buzz FX
-
Acelyrin, Inc. (NASDAQ:SLRN) Sees Large Decrease in Short Interest
04 Mar 2025 08:49:15 By Buzz FX
-
HC Wainwright Reaffirms Buy Rating for Ocular Therapeutix (NASDAQ:OCUL)
04 Mar 2025 08:49:15 By Buzz FX
-
Rosenblatt Securities Reaffirms "Buy" Rating for Canaan (NASDAQ:CAN)
04 Mar 2025 08:49:15 By Buzz FX
-
Barclays Has Lowered Expectations for Fortrea (NASDAQ:FTRE) Stock Price
04 Mar 2025 08:49:15 By Buzz FX
-
RBA minutes hawkish, Aussie edges higher
04 Mar 2025 08:49:15 By Buzz FX
-
Needham & Company LLC Reaffirms "Buy" Rating for Neumora Therapeutics (NASDAQ:NMRA)
04 Mar 2025 08:49:15 By Buzz FX